Phase 1 Low Risk Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes

Rigel Pharmaceuticals86 enrolled15 locationsNCT05308264

Withdrawn

Phase 1

A phase I study investigating the mean circulation time, biodistribution and safety of an infusion of cultured red cells (CRC) in patients with myelodysplastic syndrome (MDS) or patients in remission from haematologic malignancy

haematologic malignancy in remission and not on active treatmentvery-low or low risk myelodysplastic syndrome

Cell Therapies Pty Ltd10 enrolled2 locationsACTRN12618000661279